Predictive factors associated with relapse of stage II/III colon cancer treated with peroral anti-cancer agents in the adjuvant setting

Postoperative adjuvant chemotherapy for patients with stage III colon cancer (CC) is regarded as the standard treatment worldwide for outcome improvement and relapse prevention. Similarly, high-risk stage II CC requires adjuvant chemotherapy because of its high recurrence rate. Previous randomized c...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Clin Oncol
Hlavní autoři: Mizuuchi, Yusuke, Tanabe, Yoshitaka, Sada, Masafumi, Kitaura, Yoshiki, Nagai, Shuntaro, Watanabe, Yusuke, Tamiya, Sadafumi, Nagayoshi, Kinuko, Ohuchida, Kenoki, Nakano, Toru, Nakamura, Masafumi
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2021
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8082226/
https://ncbi.nlm.nih.gov/pubmed/33936595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2021.2284
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky